<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412024001200510</article-id>
<article-id pub-id-type="doi">10.24245/gom.v92i12.39</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Perfil sociodemográfico y evaluación de la concordancia entre pruebas de tamizaje y diagnóstico en patología cervical]]></article-title>
<article-title xml:lang="en"><![CDATA[Sociodemographic profile and assessment of concordance between screening tests and diagnosis in cervical pathology.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Alza]]></surname>
<given-names><![CDATA[Laura Catalina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mejía Pérez]]></surname>
<given-names><![CDATA[Dauris Lineth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amaya Guio]]></surname>
<given-names><![CDATA[Jairo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Colombia Departamento de Obstetricia y Ginecología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional de Colombia Departamento de Obstetricia y Ginecología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Nacional de Colombia Departamento de Obstetricia y Ginecología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>92</volume>
<numero>12</numero>
<fpage>510</fpage>
<lpage>517</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412024001200510&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412024001200510&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412024001200510&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO: Establecer el perfil demográfico y evaluar la concordancia entre pruebas de tamizaje y el diagnóstico cuando hay afecciones cervicales. Lo anterior con la meta de contribuir a la identificación correcta y oportuna de pacientes con mayor riesgo de evolución a cáncer.  MATERIALES Y MÉTODOS: Estudio descriptivo, transversal y retrospectivo efectuado con base en los datos de la unidad de patología cervical de la Subred Norte de Bogotá (enero 2018 a diciembre 2022). Parámetros de estudio: información sociodemográfica de pacientes con reporte de citología, colposcopia o biopsia; análisis estadístico descriptivo de las variables sociodemográficas y evaluación de la concordancia entre las pruebas de tamizaje y el diagnóstico.  RESULTADOS: Se incluyeron datos de 3754 pacientes con edad promedio de 39.4 años, con alta prevalencia de multiparidad (82%). La citología mostró células escamosas atípicas de significado incierto (ASCUS) como la alteración más frecuente (43.9%). Las lesiones de alto grado y carcinoma se confirmaron en la histopatología en menos del 25% de los casos. El porcentaje de antecedente de ADN-VPH durante los cinco años del estudio fue de menos del 9% y las biopsias demostraron una débil concordancia con los hallazgos de la citología (kappa = 0.36), en comparación con la colposcopia (kappa = 0.6).  CONCLUSIONES: Se subraya la necesidad de mejorar el tamizaje con ADN-VPH para una detección más precisa de lesiones cervicales. Los hallazgos resaltan la importancia de políticas públicas efectivas y programas de salud que puedan reducir la incidencia y mejorar el tratamiento de pacientes con cáncer de cuello uterino.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE: To perform the sociodemographic characterization of patients attending cervical pathology services and to study the concordance between screening and diagnostic tests that can contribute to the correct and timely identification of patients with increased risk of progression to cancer.  MATERIALS AND METHODS: Descriptive, cross-sectional, retrospective study based on data from the Cervical Pathology Unit of the Subred Norte de Bogotá (January 2018 to December 2022). Study parameters: sociodemographic information of patients with cytology, colposcopy or biopsy report; descriptive statistical analysis of sociodemographic variables and assessment of concordance between screening and diagnostic tests.  RESULTS: Data from 3754 patients with a mean age of 39.4 years were included, with a high prevalence of multiparity (82%). Cytology showed ASCUS as the most common alteration (43.9%). High-grade lesions and carcinoma were confirmed by histopathology in less than 25% of cases. The percentage of HPV-DNA history during the five years was less than 9% and biopsies showed weak concordance with cytology findings (kappa = 0.36) compared to colposcopy (kappa = 0.6).  CONCLUSIONS: The need for improved screening with HPV DNA for more accurate detection of cervical lesions is underscored. These findings highlight the importance of effective public policies and health programs that can reduce the incidence and improve the management of patients with cervical cancer.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Neoplasias cervicales uterinas]]></kwd>
<kwd lng="es"><![CDATA[colposcopia]]></kwd>
<kwd lng="es"><![CDATA[paridad]]></kwd>
<kwd lng="es"><![CDATA[células escamosas atípicas del cuello uterino]]></kwd>
<kwd lng="es"><![CDATA[infecciones por papilomavirus]]></kwd>
<kwd lng="es"><![CDATA[prevalencia]]></kwd>
<kwd lng="es"><![CDATA[incidencia]]></kwd>
<kwd lng="es"><![CDATA[pruebas diagnósticas]]></kwd>
<kwd lng="en"><![CDATA[Uterine Cervical Neoplasms]]></kwd>
<kwd lng="en"><![CDATA[Colposcopy]]></kwd>
<kwd lng="en"><![CDATA[Parity]]></kwd>
<kwd lng="en"><![CDATA[Atypical squamous cells of the cervix]]></kwd>
<kwd lng="en"><![CDATA[Papillomavirus infections]]></kwd>
<kwd lng="en"><![CDATA[Prevalence]]></kwd>
<kwd lng="en"><![CDATA[Incidence]]></kwd>
<kwd lng="en"><![CDATA[Diagnostic tests, routine]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bray BSC]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Laversanne]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sung]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ferlay]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries]]></article-title>
<source><![CDATA[CA Cancer J Clin]]></source>
<year>2024</year>
<volume>74</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>229-63</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Cancer.Net</collab>
<source><![CDATA[Cervical Cancer: Statistics]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Liga Colombiana Contra el Cáncer</collab>
<source><![CDATA[Cáncer de cuello uterino]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Secretaria de Salud de Bogotá</collab>
<source><![CDATA[Infografía / Día Mundial de la prevención del cáncer de cuello uterino]]></source>
<year>2022</year>
<publisher-name><![CDATA[SaluData Observatorio de Bogotá]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>National Cancer Institute</collab>
<source><![CDATA[Cervical Cancer Causes, Risk Factors, and Prevention]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<collab>IARC</collab>
<article-title xml:lang=""><![CDATA[Chapter 2: Interpretation of the results of cervical screening]]></article-title>
<source><![CDATA[IARC Handbooks of Cancer Prevention]]></source>
<year>2016</year>
<volume>10</volume>
<page-range>13-22</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allemani]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Weir]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
<name>
<surname><![CDATA[Carreira]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2015</year>
<volume>385</volume>
<numero>9972</numero>
<issue>9972</issue>
<page-range>977</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Vignat]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzoni]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative]]></article-title>
<source><![CDATA[Lancet Glob Health]]></source>
<year>2023</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>e197-206</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<collab>Ministerio de Salud</collab>
<source><![CDATA[Por la salud de las mujeres, eliminemos el cáncer de cuello uterino]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burger]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[De Kok]]></surname>
<given-names><![CDATA[IMCM]]></given-names>
</name>
<name>
<surname><![CDATA[Groene]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis]]></article-title>
<source><![CDATA[JNCI]]></source>
<year>2020</year>
<volume>112</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>955</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rajaram]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Screening for cervical cancer: Choices &amp; dilemmas]]></article-title>
<source><![CDATA[Indian J Med Res]]></source>
<year>2021</year>
<volume>154</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>210</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Winstead]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Why Are Many Women Overdue for Cervical Cancer Screening?]]></source>
<year>2022</year>
<publisher-name><![CDATA[ASCO Meetings]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mayorga-Bautista]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Hidalgo-Martínez]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Romo-Rodríguez M del]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Concordancia de los hallazgos citológicos, colposcópicos e histológicos en lesiones premalignas del cuello uterino]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2023</year>
<volume>91</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>32-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koliopoulos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Nyaga]]></surname>
<given-names><![CDATA[VN]]></given-names>
</name>
<name>
<surname><![CDATA[Santesso]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cytology versus HPV testing for cervical cancer screening in the general population]]></article-title>
<source><![CDATA[Cochrane Database of Systematic Reviews]]></source>
<year>2017</year>
<volume>2017</volume>
<numero>8</numero>
<issue>8</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ciendua]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hallazgos en colposcopia. Experiencia en una unidad de referencia]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2019</year>
<volume>87</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>302-10</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katz]]></surname>
<given-names><![CDATA[LMC]]></given-names>
</name>
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[ASR]]></given-names>
</name>
<name>
<surname><![CDATA[Fittipaldi]]></surname>
<given-names><![CDATA[SO]]></given-names>
</name>
<name>
<surname><![CDATA[de Santos]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Amorim]]></surname>
<given-names><![CDATA[MMR.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Agreement between cytology, colposcopy and cervical histopathology]]></article-title>
<source><![CDATA[Rev Bras Ginecol Obstet]]></source>
<year>2010</year>
<volume>32</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>368-73</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abolafia Cañete]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Monserrat Jordán]]></surname>
<given-names><![CDATA[JÁ]]></given-names>
</name>
<name>
<surname><![CDATA[Cuevas Cruces]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Arjona Berral]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico precoz del cáncer de cérvix: correlación entre citología, colposcopia y biopsia]]></article-title>
<source><![CDATA[Prog obstet ginecol]]></source>
<year>2017</year>
<page-range>314-9</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mora-Enríquez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Amaya-Guio]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Salamanca-Mora]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Monsalve-Páez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of inter-observer concordance of the Swede score for digital colposcopic images]]></article-title>
<source><![CDATA[Rev Colomb Obstet Ginecol]]></source>
<year>2019</year>
<volume>70</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>94-102</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paolino]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arrossi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Analysis of the reasons for abandoning the follow-up and treatment process in women with pre-cancerous cervical lesions in the province of Jujuy: implications for health management]]></article-title>
<source><![CDATA[Salud Colect]]></source>
<year>2012</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>247-61</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<collab>WHO</collab>
<source><![CDATA[Cervical cancer screening in developing countries: report of a WHO Consultation]]></source>
<year>2022</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
